Nanjing Pharmaceutical Co. Ltd.

Pharmaceuticals
China
Earnings Per Share Growth (%)N/A
Cost of Goods Sold (US$ Millions)$3,594
Current Liabilities (US$ Millions)$1,494
Total Assets (US$ Millions)$1,739
Long Term Debt$0
Return on Equity7.32%
Revenue (US$ Millions)$3,821
Total Company Assets$1,939
Revenue Growth (%)12.40%
Net Income (US$ Millions)$24
Earnings Per Share (US$)N/A
Total Equity (US$ Millions)$354
Profit Margin (%)0.63%
Debt To Equity Ratio (%)0.00%
Inventory Turnover$321